Medium materiality6/10
Teva Pharma (TEVA) PT Raised to $50 at JPMorgan
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
JPMorgan raises TEVA target to $50; current price is $41.10, indicating upside potential.
- JPMorgan raises TEVA target to $50; price $41.10.
- Upside potential remains.
Key facts
- 01
Target: $5
- 02
Posted price: $4.04
- 03
Analyst firm: Mizuho Securities
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.